*Some Market data delayed by 15 mins.

RxSight, Inc. Common Stock

Symbol: RXST (NASDAQ)
8.81 ▲ (2.97%) 0.254

Company Description:
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.

Key Stats
  • Today's Open: $8.6
  • Today's High: $8.845
  • Today's Low: $8.625
  • Today's Volume: 43.34K
  • Yesterday Close: $8.56
  • Yesterday High: $9.09
  • Yesterday Low: $8.55
  • Yesterday Volume: 596.47K
  • Last Min Volume: 1.22K
  • Last Min High: $8.809
  • Last Min Low: $8.795
  • Last Min VWAP: $8.79693
Company Profile
  • Name: RxSight, Inc. Common Stock
  • Website: https://www.rxsight.com
  • Listed Date: 2021-07-30
  • Location: ALISO VIEJO, CA
  • Market Status: Active
  • CIK Number: 0001111485
  • SIC Code: 3851
  • SIC description: OPHTHALMIC GOODS
  • Market Cap: $350.24M
  • Round Lot: 100
  • Outstanding Shares: 40.92M
  • Asset Type: CS
RECENT FILINGS FOR RXST
Filing Date Filing Type Format
2025-09-26 4 View
2025-08-15 8-K/A View
2025-08-13 SCHEDULE 13G/A View
2025-08-13 SCHEDULE 13G/A View
2025-08-12 SCHEDULE 13G View
2025-08-07 10-Q View
2025-08-07 8-K View
2025-08-04 4 View
2025-08-04 3 View
2025-08-04 8-K View
2025-07-15 SCHEDULE 13G View
2025-07-08 8-K View
2025-06-04 4 View
2025-06-04 4 View
2025-06-04 4 View
2025-06-04 4 View
2025-06-04 4 View
2025-06-04 4 View
2025-06-04 4 View
2025-06-04 4 View
Latest News on RXST

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.